| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | C-X3-C chemokine binding | 2.97e-05 | 5 | 35 | 2 | GO:0019960 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.61e-05 | 749 | 35 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | cadmium ion binding | 1.95e-04 | 12 | 35 | 2 | GO:0046870 | |
| GeneOntologyMolecularFunction | coreceptor activity | 2.71e-04 | 72 | 35 | 3 | GO:0015026 | |
| GeneOntologyMolecularFunction | copper ion binding | 3.43e-04 | 78 | 35 | 3 | GO:0005507 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.53e-04 | 16 | 35 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 6.14e-04 | 21 | 35 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.02e-03 | 27 | 35 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | chemokine binding | 1.52e-03 | 33 | 35 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 1.81e-03 | 36 | 35 | 2 | GO:0031624 | |
| GeneOntologyMolecularFunction | fibronectin binding | 2.02e-03 | 38 | 35 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 2.46e-03 | 42 | 35 | 2 | GO:0044390 | |
| GeneOntologyMolecularFunction | cytokine binding | 2.60e-03 | 157 | 35 | 3 | GO:0019955 | |
| GeneOntologyMolecularFunction | integrin binding | 3.52e-03 | 175 | 35 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | protease binding | 3.87e-03 | 181 | 35 | 3 | GO:0002020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.31e-03 | 188 | 35 | 3 | GO:0005201 | |
| GeneOntologyBiologicalProcess | detoxification of copper ion | 9.75e-09 | 16 | 33 | 4 | GO:0010273 | |
| GeneOntologyBiologicalProcess | stress response to copper ion | 9.75e-09 | 16 | 33 | 4 | GO:1990169 | |
| GeneOntologyBiologicalProcess | stress response to metal ion | 3.89e-08 | 22 | 33 | 4 | GO:0097501 | |
| GeneOntologyBiologicalProcess | detoxification of inorganic compound | 6.71e-08 | 25 | 33 | 4 | GO:0061687 | |
| GeneOntologyBiologicalProcess | cellular response to copper ion | 9.28e-08 | 27 | 33 | 4 | GO:0071280 | |
| GeneOntologyBiologicalProcess | cellular response to zinc ion | 1.08e-07 | 28 | 33 | 4 | GO:0071294 | |
| GeneOntologyBiologicalProcess | cellular response to chromate | 2.08e-07 | 8 | 33 | 3 | GO:0071247 | |
| GeneOntologyBiologicalProcess | response to chromate | 3.11e-07 | 9 | 33 | 3 | GO:0046687 | |
| GeneOntologyBiologicalProcess | cellular response to cadmium ion | 6.41e-07 | 43 | 33 | 4 | GO:0071276 | |
| GeneOntologyBiologicalProcess | response to copper ion | 6.41e-07 | 43 | 33 | 4 | GO:0046688 | |
| GeneOntologyBiologicalProcess | intracellular zinc ion homeostasis | 7.04e-07 | 44 | 33 | 4 | GO:0006882 | |
| GeneOntologyBiologicalProcess | response to zinc ion | 2.66e-06 | 61 | 33 | 4 | GO:0010043 | |
| GeneOntologyBiologicalProcess | molting cycle | 3.83e-06 | 150 | 33 | 5 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 3.83e-06 | 150 | 33 | 5 | GO:0042633 | |
| GeneOntologyBiologicalProcess | response to cadmium ion | 4.11e-06 | 68 | 33 | 4 | GO:0046686 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor diffusion trapping | 7.44e-06 | 3 | 33 | 2 | GO:0150054 | |
| GeneOntologyBiologicalProcess | nitric oxide mediated signal transduction | 3.54e-05 | 40 | 33 | 3 | GO:0007263 | |
| GeneOntologyBiologicalProcess | detoxification | 1.51e-04 | 170 | 33 | 4 | GO:0098754 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 1.84e-04 | 337 | 33 | 5 | GO:0006898 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 1.91e-04 | 13 | 33 | 2 | GO:0098970 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 1.91e-04 | 13 | 33 | 2 | GO:0099628 | |
| GeneOntologyBiologicalProcess | cellular response to insulin-like growth factor stimulus | 1.91e-04 | 13 | 33 | 2 | GO:1990314 | |
| GeneOntologyBiologicalProcess | receptor internalization | 1.96e-04 | 182 | 33 | 4 | GO:0031623 | |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 2.23e-04 | 14 | 33 | 2 | GO:0098953 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic specialization structure | 3.33e-04 | 17 | 33 | 2 | GO:0098880 | |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 3.97e-04 | 219 | 33 | 4 | GO:0071248 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 4.12e-04 | 91 | 33 | 3 | GO:0033627 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 4.64e-04 | 412 | 33 | 5 | GO:0090287 | |
| GeneOntologyBiologicalProcess | regulation of receptor internalization | 4.67e-04 | 95 | 33 | 3 | GO:0002090 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron apoptotic process | 5.27e-04 | 236 | 33 | 4 | GO:0043524 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter uptake | 6.70e-04 | 24 | 33 | 2 | GO:0051580 | |
| GeneOntologyBiologicalProcess | positive regulation of fibroblast migration | 8.50e-04 | 27 | 33 | 2 | GO:0010763 | |
| GeneOntologyBiologicalProcess | wound healing, spreading of epidermal cells | 9.14e-04 | 28 | 33 | 2 | GO:0035313 | |
| GeneOntologyBiologicalProcess | negative regulation of growth | 1.04e-03 | 283 | 33 | 4 | GO:0045926 | |
| GeneOntologyBiologicalProcess | response to toxic substance | 1.12e-03 | 289 | 33 | 4 | GO:0009636 | |
| GeneOntologyCellularComponent | keratin filament | KRTAP29-1 KRTAP4-4 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 4.55e-18 | 97 | 35 | 11 | GO:0045095 |
| GeneOntologyCellularComponent | intermediate filament | KRTAP29-1 KRTAP4-4 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 6.44e-14 | 227 | 35 | 11 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP29-1 KRTAP4-4 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 3.24e-13 | 263 | 35 | 11 | GO:0045111 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP29-1 KRTAP4-4 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 1.41e-07 | 899 | 35 | 11 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP29-1 KRTAP4-4 KRTAP4-6 KRTAP4-9 FBN1 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 2.44e-07 | 1179 | 35 | 12 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP29-1 KRTAP4-4 KRTAP4-6 KRTAP4-9 FBN1 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 2.62e-07 | 1187 | 35 | 12 | GO:0099081 |
| GeneOntologyCellularComponent | integrin alpha9-beta1 complex | 8.16e-06 | 3 | 35 | 2 | GO:0034679 | |
| GeneOntologyCellularComponent | glycinergic synapse | 5.08e-04 | 20 | 35 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | basement membrane | 1.11e-03 | 122 | 35 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | integrin complex | 1.31e-03 | 32 | 35 | 2 | GO:0008305 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.62e-03 | 519 | 35 | 5 | GO:0009897 | |
| GeneOntologyCellularComponent | lysosome | 2.07e-03 | 811 | 35 | 6 | GO:0005764 | |
| GeneOntologyCellularComponent | lytic vacuole | 2.07e-03 | 811 | 35 | 6 | GO:0000323 | |
| GeneOntologyCellularComponent | vacuole | 3.74e-03 | 913 | 35 | 6 | GO:0005773 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 4.39e-03 | 59 | 35 | 2 | GO:0098636 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 4.52e-03 | 405 | 35 | 4 | GO:0045211 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 5.30e-03 | 212 | 35 | 3 | GO:0030666 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 9.40e-03 | 785 | 35 | 5 | GO:0098797 | |
| GeneOntologyCellularComponent | cell surface | 9.60e-03 | 1111 | 35 | 6 | GO:0009986 | |
| GeneOntologyCellularComponent | platelet alpha granule | 1.06e-02 | 93 | 35 | 2 | GO:0031091 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 1.11e-02 | 817 | 35 | 5 | GO:0098978 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.15e-02 | 530 | 35 | 4 | GO:0062023 | |
| MousePheno | abnormal vertebral column morphology | 2.06e-05 | 787 | 17 | 7 | MP:0004703 | |
| MousePheno | increased embryonic neuroepithelium thickness | 2.91e-05 | 7 | 17 | 2 | MP:0012702 | |
| MousePheno | abnormal spine curvature | 2.92e-05 | 318 | 17 | 5 | MP:0004174 | |
| MousePheno | abnormal heart left ventricle size | 4.34e-05 | 169 | 17 | 4 | MP:0010578 | |
| MousePheno | craniofacial phenotype | 9.11e-05 | 1372 | 17 | 8 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 9.11e-05 | 1372 | 17 | 8 | MP:0000428 | |
| MousePheno | abnormal phalanx morphology | 9.94e-05 | 76 | 17 | 3 | MP:0005306 | |
| MousePheno | abnormal heart ventricle size | 1.39e-04 | 228 | 17 | 4 | MP:0031543 | |
| MousePheno | abnormal axial skeleton morphology | 1.41e-04 | 1458 | 17 | 8 | MP:0002114 | |
| MousePheno | abnormal blood coagulation | 1.69e-04 | 240 | 17 | 4 | MP:0002551 | |
| MousePheno | abnormal thoracic cage morphology | 1.73e-04 | 463 | 17 | 5 | MP:0004624 | |
| MousePheno | abnormal hemostasis | 1.75e-04 | 242 | 17 | 4 | MP:0009676 | |
| MousePheno | abnormal food intake | 2.07e-04 | 481 | 17 | 5 | MP:0005449 | |
| MousePheno | abnormal rib morphology | 2.20e-04 | 257 | 17 | 4 | MP:0000150 | |
| MousePheno | abnormal heart ventricle morphology | 2.36e-04 | 793 | 17 | 6 | MP:0005294 | |
| MousePheno | abnormal thrombosis | 2.67e-04 | 106 | 17 | 3 | MP:0005048 | |
| MousePheno | abnormal cranium morphology | 2.70e-04 | 813 | 17 | 6 | MP:0000438 | |
| MousePheno | abnormal craniofacial bone morphology | 2.96e-04 | 827 | 17 | 6 | MP:0002116 | |
| MousePheno | abnormal platelet physiology | 2.97e-04 | 110 | 17 | 3 | MP:0005464 | |
| MousePheno | abnormal digit development | 3.47e-04 | 23 | 17 | 2 | MP:0006280 | |
| MousePheno | abnormal digit morphology | 5.25e-04 | 323 | 17 | 4 | MP:0002110 | |
| MousePheno | increased heart left ventricle size | 5.31e-04 | 134 | 17 | 3 | MP:0010579 | |
| MousePheno | abnormal viscerocranium morphology | 5.46e-04 | 593 | 17 | 5 | MP:0005274 | |
| MousePheno | diaphragmatic hernia | 5.54e-04 | 29 | 17 | 2 | MP:0003924 | |
| MousePheno | decreased susceptibility to induced thrombosis | 5.94e-04 | 30 | 17 | 2 | MP:0031120 | |
| MousePheno | abnormal eating behavior | 5.94e-04 | 604 | 17 | 5 | MP:0001431 | |
| MousePheno | abnormal limb development | 6.03e-04 | 140 | 17 | 3 | MP:0006279 | |
| MousePheno | abnormal heart left ventricle weight | 8.56e-04 | 36 | 17 | 2 | MP:0020204 | |
| MousePheno | abnormal heart left ventricle morphology | 8.66e-04 | 369 | 17 | 4 | MP:0003921 | |
| MousePheno | abnormal metacarpal bone morphology | 9.04e-04 | 37 | 17 | 2 | MP:0003073 | |
| MousePheno | hemorrhage | 9.14e-04 | 664 | 17 | 5 | MP:0001914 | |
| MousePheno | abnormal limb morphology | 9.52e-04 | 1028 | 17 | 6 | MP:0002109 | |
| MousePheno | internal hemorrhage | 1.03e-03 | 387 | 17 | 4 | MP:0001634 | |
| MousePheno | abnormal autopod morphology | 1.06e-03 | 390 | 17 | 4 | MP:0000572 | |
| MousePheno | abnormal consumption behavior | 1.12e-03 | 695 | 17 | 5 | MP:0002069 | |
| MousePheno | increased heart ventricle size | 1.15e-03 | 175 | 17 | 3 | MP:0008772 | |
| MousePheno | abnormal tumor pathology | 1.17e-03 | 176 | 17 | 3 | MP:0010639 | |
| MousePheno | abnormal bone remodeling | 1.21e-03 | 178 | 17 | 3 | MP:0002998 | |
| MousePheno | postnatal lethality | 1.26e-03 | 1084 | 17 | 6 | MP:0002082 | |
| MousePheno | decreased body fat mass | 1.40e-03 | 46 | 17 | 2 | MP:0014143 | |
| MousePheno | increased tumor growth/size | 1.52e-03 | 48 | 17 | 2 | MP:0003721 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | 1.52e-03 | 1124 | 17 | 6 | MP:0011112 | |
| MousePheno | lethality throughout fetal growth and development | 1.59e-03 | 435 | 17 | 4 | MP:0006208 | |
| MousePheno | abnormal susceptibility to induced thrombosis | 1.85e-03 | 53 | 17 | 2 | MP:0020408 | |
| MousePheno | lethality throughout fetal growth and development, incomplete penetrance | 1.89e-03 | 208 | 17 | 3 | MP:0011109 | |
| MousePheno | abnormal skin appearance | 2.17e-03 | 473 | 17 | 4 | MP:0009931 | |
| MousePheno | abnormal presacral vertebrae morphology | 2.37e-03 | 225 | 17 | 3 | MP:0000459 | |
| MousePheno | kyphosis | 2.49e-03 | 229 | 17 | 3 | MP:0000160 | |
| MousePheno | abnormal blood circulation | 2.68e-03 | 845 | 17 | 5 | MP:0002128 | |
| MousePheno | abnormal metastatic potential | 2.68e-03 | 64 | 17 | 2 | MP:0000858 | |
| MousePheno | limbs/digits/tail phenotype | 2.72e-03 | 1258 | 17 | 6 | MP:0005371 | |
| MousePheno | abnormal temporal bone morphology | 2.85e-03 | 66 | 17 | 2 | MP:0005272 | |
| MousePheno | abnormal posture | 2.95e-03 | 243 | 17 | 3 | MP:0001504 | |
| MousePheno | micrognathia | 3.02e-03 | 68 | 17 | 2 | MP:0002639 | |
| MousePheno | abnormal cell adhesion | 3.11e-03 | 69 | 17 | 2 | MP:0003566 | |
| MousePheno | abnormal jaw morphology | 3.28e-03 | 530 | 17 | 4 | MP:0000454 | |
| MousePheno | abnormal appendicular skeleton morphology | 3.46e-03 | 896 | 17 | 5 | MP:0009250 | |
| MousePheno | abnormal vertebrae morphology | 3.65e-03 | 546 | 17 | 4 | MP:0000137 | |
| Domain | KAP | KRTAP29-1 KRTAP4-4 KRTAP4-7 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 4.16e-22 | 58 | 37 | 12 | IPR002494 |
| Domain | Keratin_B2 | KRTAP4-4 KRTAP4-7 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 7.90e-22 | 40 | 37 | 11 | PF01500 |
| Domain | Keratin_B2_2 | KRTAP29-1 KRTAP4-4 KRTAP4-6 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 | 3.33e-17 | 39 | 37 | 9 | PF13885 |
| Domain | METALLOTHIONEIN_VRT | 2.93e-11 | 13 | 37 | 5 | PS00203 | |
| Domain | Metalthion_vert | 4.55e-11 | 14 | 37 | 5 | IPR000006 | |
| Domain | Metalthion | 4.55e-11 | 14 | 37 | 5 | IPR003019 | |
| Domain | Metallothio | 4.55e-11 | 14 | 37 | 5 | PF00131 | |
| Domain | EGF_1 | 4.75e-11 | 255 | 37 | 10 | PS00022 | |
| Domain | EGF-like_CS | 1.57e-09 | 261 | 37 | 9 | IPR013032 | |
| Domain | EGF_2 | 1.79e-09 | 265 | 37 | 9 | PS01186 | |
| Domain | Metalthion_dom_vert | 6.38e-09 | 12 | 37 | 4 | IPR023587 | |
| Domain | Metalthion_dom | 6.38e-09 | 12 | 37 | 4 | IPR017854 | |
| Domain | - | 6.38e-09 | 12 | 37 | 4 | 4.10.10.10 | |
| Domain | EGF_3 | 1.57e-08 | 235 | 37 | 8 | PS50026 | |
| Domain | EGF | 1.57e-08 | 235 | 37 | 8 | SM00181 | |
| Domain | Growth_fac_rcpt_ | 2.07e-08 | 156 | 37 | 7 | IPR009030 | |
| Domain | EGF-like_dom | 2.47e-08 | 249 | 37 | 8 | IPR000742 | |
| Domain | EGF_CA | 1.35e-07 | 122 | 37 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.49e-07 | 124 | 37 | 6 | IPR001881 | |
| Domain | cEGF | 1.89e-07 | 26 | 37 | 4 | IPR026823 | |
| Domain | cEGF | 1.89e-07 | 26 | 37 | 4 | PF12662 | |
| Domain | EGF_CA | 7.14e-07 | 86 | 37 | 5 | PF07645 | |
| Domain | Metalthion_vert_metal_BS | 8.51e-07 | 10 | 37 | 3 | IPR018064 | |
| Domain | EGF_Ca-bd_CS | 1.30e-06 | 97 | 37 | 5 | IPR018097 | |
| Domain | EGF_CA | 1.44e-06 | 99 | 37 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.51e-06 | 100 | 37 | 5 | PS00010 | |
| Domain | EGF_3 | 1.56e-06 | 12 | 37 | 3 | PF12947 | |
| Domain | EGF_dom | 1.56e-06 | 12 | 37 | 3 | IPR024731 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.02e-06 | 106 | 37 | 5 | IPR000152 | |
| Domain | EGF | 4.73e-06 | 126 | 37 | 5 | PF00008 | |
| Domain | EGF_extracell | 5.87e-06 | 60 | 37 | 4 | IPR013111 | |
| Domain | EGF_2 | 5.87e-06 | 60 | 37 | 4 | PF07974 | |
| Domain | - | 2.29e-05 | 4 | 37 | 2 | 1.20.5.630 | |
| Domain | Integrin_bsu_cyt_dom | 5.70e-05 | 6 | 37 | 2 | IPR014836 | |
| Domain | Integrin_b_cyt | 5.70e-05 | 6 | 37 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 5.70e-05 | 6 | 37 | 2 | PF08725 | |
| Domain | Integrin_bsu_tail | 7.97e-05 | 7 | 37 | 2 | IPR012896 | |
| Domain | Integrin_B_tail | 7.97e-05 | 7 | 37 | 2 | SM01242 | |
| Domain | Integrin_B_tail | 7.97e-05 | 7 | 37 | 2 | PF07965 | |
| Domain | PSI | 8.96e-05 | 44 | 37 | 3 | IPR016201 | |
| Domain | PSI | 1.02e-04 | 46 | 37 | 3 | SM00423 | |
| Domain | INB | 1.06e-04 | 8 | 37 | 2 | SM00187 | |
| Domain | Integrin_beta | 1.06e-04 | 8 | 37 | 2 | PF00362 | |
| Domain | Integrin_bsu_VWA | 1.06e-04 | 8 | 37 | 2 | IPR002369 | |
| Domain | CUB | 1.24e-04 | 49 | 37 | 3 | PF00431 | |
| Domain | CUB | 1.32e-04 | 50 | 37 | 3 | SM00042 | |
| Domain | Integrin_bsu | 1.36e-04 | 9 | 37 | 2 | IPR015812 | |
| Domain | INTEGRIN_BETA | 1.36e-04 | 9 | 37 | 2 | PS00243 | |
| Domain | PSI_integrin | 1.36e-04 | 9 | 37 | 2 | PF17205 | |
| Domain | Integin_beta_N | 1.36e-04 | 9 | 37 | 2 | IPR033760 | |
| Domain | - | 1.48e-04 | 52 | 37 | 3 | 2.60.120.290 | |
| Domain | CUB | 1.57e-04 | 53 | 37 | 3 | PS01180 | |
| Domain | E3_UB_ligase_RBR | 1.70e-04 | 10 | 37 | 2 | IPR031127 | |
| Domain | CUB_dom | 1.95e-04 | 57 | 37 | 3 | IPR000859 | |
| Domain | - | 2.08e-04 | 11 | 37 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 2.08e-04 | 11 | 37 | 2 | IPR023413 | |
| Domain | Ephrin_rec_like | 2.08e-04 | 11 | 37 | 2 | PF07699 | |
| Domain | Ldl_recept_b | 3.42e-04 | 14 | 37 | 2 | PF00058 | |
| Domain | LDLRB | 3.42e-04 | 14 | 37 | 2 | PS51120 | |
| Domain | IBR | 3.42e-04 | 14 | 37 | 2 | PF01485 | |
| Domain | IBR | 3.42e-04 | 14 | 37 | 2 | SM00647 | |
| Domain | IBR_dom | 3.95e-04 | 15 | 37 | 2 | IPR002867 | |
| Domain | LY | 3.95e-04 | 15 | 37 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.95e-04 | 15 | 37 | 2 | IPR000033 | |
| Domain | VWC_out | 6.39e-04 | 19 | 37 | 2 | SM00215 | |
| Domain | Ephrin_rec_like | 1.11e-03 | 25 | 37 | 2 | SM01411 | |
| Domain | Integrin_dom | 1.11e-03 | 25 | 37 | 2 | IPR032695 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.11e-03 | 25 | 37 | 2 | IPR011641 | |
| Domain | EGF_LAM_2 | 1.60e-03 | 30 | 37 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 1.60e-03 | 30 | 37 | 2 | PS01248 | |
| Domain | EGF_Lam | 2.18e-03 | 35 | 37 | 2 | SM00180 | |
| Domain | VWFC_1 | 2.31e-03 | 36 | 37 | 2 | PS01208 | |
| Domain | VWC | 2.57e-03 | 38 | 37 | 2 | SM00214 | |
| Domain | Laminin_EGF | 2.57e-03 | 38 | 37 | 2 | IPR002049 | |
| Domain | VWFC_2 | 2.57e-03 | 38 | 37 | 2 | PS50184 | |
| Domain | - | 2.70e-03 | 39 | 37 | 2 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 2.84e-03 | 40 | 37 | 2 | IPR023415 | |
| Domain | VWF_dom | 3.13e-03 | 42 | 37 | 2 | IPR001007 | |
| Domain | Ldl_recept_a | 3.58e-03 | 45 | 37 | 2 | PF00057 | |
| Domain | - | 3.74e-03 | 46 | 37 | 2 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.74e-03 | 46 | 37 | 2 | IPR011042 | |
| Domain | LDLRA_1 | 4.07e-03 | 48 | 37 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 4.24e-03 | 49 | 37 | 2 | IPR002172 | |
| Domain | LDLa | 4.24e-03 | 49 | 37 | 2 | SM00192 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP29-1 KRTAP4-4 KRTAP4-7 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 2.69e-12 | 217 | 35 | 11 | M27640 |
| Pathway | REACTOME_KERATINIZATION | KRTAP29-1 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 9.15e-11 | 153 | 35 | 9 | MM15343 |
| Pathway | REACTOME_METALLOTHIONEINS_BIND_METALS | 1.04e-08 | 11 | 35 | 4 | M27543 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP29-1 KRTAP4-6 KRTAP4-9 KRTAP4-1 ITGB1 KRTAP4-12 ITGB3 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 2.01e-08 | 502 | 35 | 11 | MM14537 |
| Pathway | WP_ZINC_HOMEOSTASIS | 2.88e-08 | 37 | 35 | 5 | M39377 | |
| Pathway | REACTOME_RESPONSE_TO_METAL_IONS | 3.13e-08 | 14 | 35 | 4 | M27541 | |
| Pathway | WP_COPPER_HOMEOSTASIS | 1.85e-07 | 53 | 35 | 5 | M39349 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP29-1 KRTAP4-4 KRTAP4-7 KRTAP4-6 KRTAP4-9 EGF KRTAP4-1 ITGB1 KRTAP4-2 ITGB3 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 3.47e-06 | 1432 | 35 | 14 | M509 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.62e-05 | 32 | 35 | 3 | MM14854 | |
| Pathway | WP_OXIDATIVE_STRESS_RESPONSE | 9.46e-05 | 36 | 35 | 3 | MM15941 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.03e-04 | 37 | 35 | 3 | M27134 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.11e-04 | 38 | 35 | 3 | MM14874 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.21e-04 | 39 | 35 | 3 | MM14601 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 1.51e-04 | 42 | 35 | 3 | M174 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.73e-04 | 44 | 35 | 3 | M26969 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.11e-04 | 47 | 35 | 3 | M646 | |
| Pathway | BIOCARTA_UCALPAIN_PATHWAY | 3.89e-04 | 12 | 35 | 2 | MM1525 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.09e-04 | 258 | 35 | 5 | MM14572 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 5.35e-04 | 14 | 35 | 2 | MM14923 | |
| Pathway | BIOCARTA_UCALPAIN_PATHWAY | 5.35e-04 | 14 | 35 | 2 | M13143 | |
| Pathway | WP_LUNG_FIBROSIS | 7.74e-04 | 73 | 35 | 3 | MM15827 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.12e-04 | 300 | 35 | 5 | M610 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.71e-04 | 76 | 35 | 3 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 9.04e-04 | 77 | 35 | 3 | MM14670 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 9.97e-04 | 19 | 35 | 2 | MM1434 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 9.97e-04 | 19 | 35 | 2 | M8719 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 9.97e-04 | 19 | 35 | 2 | MM15113 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.20e-03 | 85 | 35 | 3 | M16441 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 1.22e-03 | 21 | 35 | 2 | M878 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 1.47e-03 | 23 | 35 | 2 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 1.47e-03 | 23 | 35 | 2 | M47720 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.61e-03 | 94 | 35 | 3 | M1041 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.87e-03 | 26 | 35 | 2 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 1.87e-03 | 26 | 35 | 2 | M47719 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.02e-03 | 27 | 35 | 2 | M27217 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 2.17e-03 | 28 | 35 | 2 | M47655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 2.49e-03 | 30 | 35 | 2 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 2.49e-03 | 30 | 35 | 2 | M47718 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.79e-03 | 114 | 35 | 3 | MM14571 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.83e-03 | 32 | 35 | 2 | MM14924 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.08e-03 | 118 | 35 | 3 | MM15588 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 3.30e-03 | 121 | 35 | 3 | M39823 | |
| Pathway | PID_ARF6_PATHWAY | 3.38e-03 | 35 | 35 | 2 | M86 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 3.72e-03 | 828 | 35 | 7 | M27827 | |
| Pubmed | KRTAP4-4 KRTAP4-7 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 3.19e-25 | 37 | 37 | 11 | 11279113 | |
| Pubmed | KRTAP4-4 KRTAP4-7 KRTAP4-6 KRTAP4-1 KRTAP4-3 KRTAP4-8 KRTAP4-11 | 6.74e-21 | 8 | 37 | 7 | 15955084 | |
| Pubmed | KRTAP29-1 KRTAP4-6 KRTAP4-1 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 5.82e-15 | 69 | 37 | 8 | 18721477 | |
| Pubmed | 1.36e-10 | 9 | 37 | 4 | 15033980 | ||
| Pubmed | Activation of the complete mouse metallothionein gene locus in the maternal deciduum. | 3.56e-10 | 11 | 37 | 4 | 8720110 | |
| Pubmed | 3.56e-10 | 11 | 37 | 4 | 8003488 | ||
| Pubmed | Molecular properties and chromosomal location of cadherin-8. | 1.95e-09 | 16 | 37 | 4 | 9521872 | |
| Pubmed | 1.11e-08 | 5 | 37 | 3 | 12807887 | ||
| Pubmed | Mapping of the genes encoding mouse prostaglandin D, E, and F and prostacyclin receptors. | 1.13e-08 | 24 | 37 | 4 | 8833158 | |
| Pubmed | 1.27e-08 | 71 | 37 | 5 | 33541421 | ||
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 17158881 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 19344729 | ||
| Pubmed | Fine mapping of a mouse metallothionein gene metal response element. | 6.18e-08 | 8 | 37 | 3 | 2725504 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 22533418 | ||
| Pubmed | Metallothionein-1 suppresses rheumatoid arthritis pathogenesis by shifting the Th17/Treg balance. | 6.18e-08 | 8 | 37 | 3 | 30055006 | |
| Pubmed | Hypothermia enhances induction of protective protein metallothionein under ischemia. | 6.18e-08 | 8 | 37 | 3 | 23374901 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 28134760 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 19914257 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 7254320 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 15606775 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 6276022 | ||
| Pubmed | Cloning and sequencing of cDNA for mouse liver metallothionein-I. | 6.18e-08 | 8 | 37 | 3 | 6277322 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 21467744 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 19386279 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 14627804 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 16930132 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 22819979 | ||
| Pubmed | The ontogeny of expression of murine metallothionein: comparison with the alpha-fetoprotein gene. | 6.18e-08 | 8 | 37 | 3 | 6202573 | |
| Pubmed | Dietary zinc and metallothionein on small intestinal disaccharidases activity in mice. | 6.18e-08 | 8 | 37 | 3 | 21253395 | |
| Pubmed | Differential expression of the metallothionein gene in liver and brain of mice and rats. | 6.18e-08 | 8 | 37 | 3 | 8470112 | |
| Pubmed | Localization of metallothionein in the brain of rat and mouse. | 6.18e-08 | 8 | 37 | 3 | 1552172 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 24163136 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 7645027 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 19490933 | ||
| Pubmed | Heme-hemopexin-mediated induction of metallothionein gene expression. | 6.18e-08 | 8 | 37 | 3 | 1644822 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 11309296 | ||
| Pubmed | Dual Opposing Roles of Metallothionein Overexpression in C57BL/6J Mouse Pancreatic β-Cells. | 6.18e-08 | 8 | 37 | 3 | 26335571 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 8415626 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 33964119 | ||
| Pubmed | Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts. | 6.18e-08 | 8 | 37 | 3 | 15039454 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 15139010 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 24440343 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 20127815 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 19583814 | ||
| Pubmed | Paraquat reduces natural killer cell activity via metallothionein induction. | 6.18e-08 | 8 | 37 | 3 | 25496228 | |
| Pubmed | Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart. | 6.18e-08 | 8 | 37 | 3 | 22523246 | |
| Pubmed | Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering. | 6.18e-08 | 8 | 37 | 3 | 8495976 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 33532613 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 20056912 | ||
| Pubmed | Amplification of the metallothionein-I gene in cadmium-resistant mouse cells. | 6.18e-08 | 8 | 37 | 3 | 6941274 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 10830785 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 12638735 | ||
| Pubmed | Zinc, immune plasticity, aging, and successful aging: role of metallothionein. | 6.18e-08 | 8 | 37 | 3 | 15247005 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 27177022 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 7925998 | ||
| Pubmed | Metallothionein isogene transcription in red blood cell precursors from human cord blood. | 6.18e-08 | 8 | 37 | 3 | 11168427 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 29269399 | ||
| Pubmed | Isolation and characterization of the mouse metallothionein-I gene. | 6.18e-08 | 8 | 37 | 3 | 6935664 | |
| Pubmed | Impact of overexpression of metallothionein-1 on cell cycle progression and zinc toxicity. | 6.18e-08 | 8 | 37 | 3 | 18815222 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 10631978 | ||
| Pubmed | Transgenic mouse blastocysts that overexpress metallothionein-I resist cadmium toxicity in vitro. | 6.18e-08 | 8 | 37 | 3 | 8824913 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 21866758 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 24284788 | ||
| Pubmed | Cloning and characterization of the metallothionein-I gene from mouse LMTK cells. | 6.18e-08 | 8 | 37 | 3 | 2824133 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 17114818 | ||
| Pubmed | Metallothionein-human GH fusion genes stimulate growth of mice. | 6.18e-08 | 8 | 37 | 3 | 6356363 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 32415999 | ||
| Pubmed | CpG Site-Specific Regulation of Metallothionein-1 Gene Expression. | 6.18e-08 | 8 | 37 | 3 | 32824906 | |
| Pubmed | Mouse liver metallothioneins. Complete amino acid sequence of metallothionein-I. | 6.18e-08 | 8 | 37 | 3 | 914867 | |
| Pubmed | Protective role of metallothionein against copper depletion. | 6.18e-08 | 8 | 37 | 3 | 16759633 | |
| Pubmed | Influence of NH-Sgamma bonding interactions on the structure and dynamics of metallothioneins. | 6.18e-08 | 8 | 37 | 3 | 19609577 | |
| Pubmed | Chromosome assignments of genes for rat ceruloplasmin (CP) and metallothionein (MT). | 6.18e-08 | 8 | 37 | 3 | 8404063 | |
| Pubmed | Mapping of eight testis-specific genes to mouse chromosomes. | 6.23e-08 | 36 | 37 | 4 | 9403069 | |
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 1779826 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 30557628 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 1588441 | ||
| Pubmed | DNA variants with telomere probe enable genetic mapping of ends of mouse chromosomes. | 9.27e-08 | 9 | 37 | 3 | 1686839 | |
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 21913972 | ||
| Pubmed | Epidermal proliferation of the skin in metallothionein-null mice. | 9.27e-08 | 9 | 37 | 3 | 9506445 | |
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 19254786 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 17409522 | ||
| Pubmed | Gene expression profiles in the liver and kidney of metallothionein-null mice. | 9.27e-08 | 9 | 37 | 3 | 15913548 | |
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 15520181 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 10099782 | ||
| Pubmed | Atrophy of large myelinated axons in metallothionein-I, II knockout mice. | 9.27e-08 | 9 | 37 | 3 | 16133945 | |
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 15979673 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 15306638 | ||
| Pubmed | Metallothionein messenger RNA regulation in the mottled mouse and Menkes kinky hair syndrome. | 9.27e-08 | 9 | 37 | 3 | 3571489 | |
| Pubmed | Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice. | 9.27e-08 | 9 | 37 | 3 | 16936113 | |
| Pubmed | Decreased neurofilament density in large myelinated axons of metallothionein-I, II knockout mice. | 9.27e-08 | 9 | 37 | 3 | 16600496 | |
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 17031522 | ||
| Pubmed | Trace metal, acute phase and metabolic response to endotoxin in metallothionein-null mice. | 9.27e-08 | 9 | 37 | 3 | 8615771 | |
| Pubmed | Copper-metallothionein in the kidney of macular mice: a model for Menkes disease. | 9.27e-08 | 9 | 37 | 3 | 9358851 | |
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 18579766 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 18239062 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 8619230 | ||
| Pubmed | Distribution and retention of cadmium in metallothionein I and II null mice. | 9.27e-08 | 9 | 37 | 3 | 8619234 | |
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 24138881 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 15071173 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 11160536 | ||
| Interaction | SMCP interactions | KRTAP4-4 MT1B KRTAP4-7 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-11 KRTAP1-1 | 2.84e-13 | 79 | 31 | 8 | int:SMCP |
| Interaction | LCE3E interactions | 3.74e-10 | 60 | 31 | 6 | int:LCE3E | |
| Interaction | CATSPER1 interactions | KRTAP4-4 KRTAP4-7 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-11 KRTAP1-1 | 7.33e-10 | 126 | 31 | 7 | int:CATSPER1 |
| Interaction | LCE3C interactions | 7.41e-10 | 67 | 31 | 6 | int:LCE3C | |
| Interaction | LCE1D interactions | 9.70e-10 | 70 | 31 | 6 | int:LCE1D | |
| Interaction | LCE3D interactions | 1.26e-09 | 73 | 31 | 6 | int:LCE3D | |
| Interaction | LCE2D interactions | 1.36e-09 | 74 | 31 | 6 | int:LCE2D | |
| Interaction | LCE3A interactions | 1.61e-09 | 76 | 31 | 6 | int:LCE3A | |
| Interaction | LCE1A interactions | 2.96e-09 | 84 | 31 | 6 | int:LCE1A | |
| Interaction | OTX1 interactions | KRTAP4-4 KRTAP4-7 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-11 KRTAP1-1 | 3.13e-09 | 155 | 31 | 7 | int:OTX1 |
| Interaction | LCE1B interactions | 3.18e-09 | 85 | 31 | 6 | int:LCE1B | |
| Interaction | LCE2C interactions | 3.93e-09 | 88 | 31 | 6 | int:LCE2C | |
| Interaction | LCE5A interactions | 4.51e-09 | 90 | 31 | 6 | int:LCE5A | |
| Interaction | LCE1F interactions | 5.15e-09 | 92 | 31 | 6 | int:LCE1F | |
| Interaction | KRTAP5-6 interactions | 5.87e-09 | 94 | 31 | 6 | int:KRTAP5-6 | |
| Interaction | LCE3B interactions | 8.05e-09 | 46 | 31 | 5 | int:LCE3B | |
| Interaction | KRTAP5-4 interactions | 4.05e-08 | 63 | 31 | 5 | int:KRTAP5-4 | |
| Interaction | KRTAP10-11 interactions | 4.39e-08 | 64 | 31 | 5 | int:KRTAP10-11 | |
| Interaction | HOXA1 interactions | KRTAP4-4 KRTAP4-7 FBN1 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-11 KRTAP1-1 | 4.85e-08 | 356 | 31 | 8 | int:HOXA1 |
| Interaction | CRCT1 interactions | 5.14e-08 | 66 | 31 | 5 | int:CRCT1 | |
| Interaction | KRTAP5-3 interactions | 5.14e-08 | 66 | 31 | 5 | int:KRTAP5-3 | |
| Interaction | LCE1E interactions | 5.98e-08 | 68 | 31 | 5 | int:LCE1E | |
| Interaction | LCE2A interactions | 6.44e-08 | 69 | 31 | 5 | int:LCE2A | |
| Interaction | KRTAP9-3 interactions | 6.44e-08 | 140 | 31 | 6 | int:KRTAP9-3 | |
| Interaction | KRTAP9-2 interactions | 9.33e-08 | 149 | 31 | 6 | int:KRTAP9-2 | |
| Interaction | LCE4A interactions | 1.36e-07 | 80 | 31 | 5 | int:LCE4A | |
| Interaction | KRTAP4-4 interactions | 1.45e-07 | 81 | 31 | 5 | int:KRTAP4-4 | |
| Interaction | LCE2B interactions | 1.45e-07 | 81 | 31 | 5 | int:LCE2B | |
| Interaction | POU4F2 interactions | 1.64e-07 | 83 | 31 | 5 | int:POU4F2 | |
| Interaction | CREB5 interactions | 1.65e-07 | 164 | 31 | 6 | int:CREB5 | |
| Interaction | KRTAP26-1 interactions | 3.06e-07 | 94 | 31 | 5 | int:KRTAP26-1 | |
| Interaction | SHFL interactions | 3.58e-07 | 97 | 31 | 5 | int:SHFL | |
| Interaction | KRTAP9-8 interactions | 4.17e-07 | 100 | 31 | 5 | int:KRTAP9-8 | |
| Interaction | GNE interactions | 5.07e-07 | 104 | 31 | 5 | int:GNE | |
| Interaction | KRTAP1-1 interactions | 9.02e-07 | 219 | 31 | 6 | int:KRTAP1-1 | |
| Interaction | ZDHHC15 interactions | 1.26e-06 | 125 | 31 | 5 | int:ZDHHC15 | |
| Interaction | KRTAP4-2 interactions | 1.66e-06 | 132 | 31 | 5 | int:KRTAP4-2 | |
| Interaction | KRTAP5-2 interactions | 2.40e-06 | 62 | 31 | 4 | int:KRTAP5-2 | |
| Interaction | NPDC1 interactions | 2.90e-06 | 65 | 31 | 4 | int:NPDC1 | |
| Interaction | KRTAP10-1 interactions | 3.42e-06 | 153 | 31 | 5 | int:KRTAP10-1 | |
| Interaction | KRTAP5-7 interactions | 4.14e-06 | 71 | 31 | 4 | int:KRTAP5-7 | |
| Interaction | VASN interactions | 4.26e-06 | 160 | 31 | 5 | int:VASN | |
| Interaction | KRTAP10-5 interactions | 4.26e-06 | 160 | 31 | 5 | int:KRTAP10-5 | |
| Interaction | LCE1C interactions | 5.73e-06 | 77 | 31 | 4 | int:LCE1C | |
| Interaction | NECTIN3 interactions | 6.03e-06 | 78 | 31 | 4 | int:NECTIN3 | |
| Interaction | SLC23A1 interactions | 8.37e-06 | 26 | 31 | 3 | int:SLC23A1 | |
| Interaction | KRTAP10-6 interactions | 9.76e-06 | 88 | 31 | 4 | int:KRTAP10-6 | |
| Interaction | GLRX3 interactions | 1.01e-05 | 191 | 31 | 5 | int:GLRX3 | |
| Interaction | KRTAP4-11 interactions | 1.16e-05 | 92 | 31 | 4 | int:KRTAP4-11 | |
| Interaction | KRTAP2-3 interactions | 1.32e-05 | 95 | 31 | 4 | int:KRTAP2-3 | |
| Interaction | KRTAP5-9 interactions | 1.36e-05 | 203 | 31 | 5 | int:KRTAP5-9 | |
| Interaction | FAM76B interactions | 1.56e-05 | 99 | 31 | 4 | int:FAM76B | |
| Interaction | KRTAP2-4 interactions | 1.69e-05 | 101 | 31 | 4 | int:KRTAP2-4 | |
| Interaction | ADAMTSL4 interactions | 1.87e-05 | 217 | 31 | 5 | int:ADAMTSL4 | |
| Interaction | SCUBE1 interactions | 2.28e-05 | 5 | 31 | 2 | int:SCUBE1 | |
| Interaction | KRTAP10-8 interactions | 2.89e-05 | 401 | 31 | 6 | int:KRTAP10-8 | |
| Interaction | KRTAP10-9 interactions | 3.09e-05 | 241 | 31 | 5 | int:KRTAP10-9 | |
| Interaction | ZNF440 interactions | 3.13e-05 | 40 | 31 | 3 | int:ZNF440 | |
| Interaction | MT1B interactions | 3.42e-05 | 6 | 31 | 2 | int:MT1B | |
| Interaction | NUFIP2 interactions | 3.60e-05 | 417 | 31 | 6 | int:NUFIP2 | |
| Interaction | ZNF497 interactions | 4.18e-05 | 44 | 31 | 3 | int:ZNF497 | |
| Interaction | KRTAP1-5 interactions | 5.44e-05 | 48 | 31 | 3 | int:KRTAP1-5 | |
| Interaction | KRTAP17-1 interactions | 5.44e-05 | 48 | 31 | 3 | int:KRTAP17-1 | |
| Interaction | AQP1 interactions | 5.74e-05 | 138 | 31 | 4 | int:AQP1 | |
| Interaction | SCUBE3 interactions | 6.38e-05 | 8 | 31 | 2 | int:SCUBE3 | |
| Interaction | DHRS1 interactions | 6.53e-05 | 51 | 31 | 3 | int:DHRS1 | |
| Interaction | ZNF408 interactions | 6.95e-05 | 145 | 31 | 4 | int:ZNF408 | |
| Interaction | KRTAP10-3 interactions | 7.95e-05 | 294 | 31 | 5 | int:KRTAP10-3 | |
| Interaction | FBXO34 interactions | 8.19e-05 | 55 | 31 | 3 | int:FBXO34 | |
| Interaction | SPRY2 interactions | 8.35e-05 | 152 | 31 | 4 | int:SPRY2 | |
| Interaction | ZFP41 interactions | 9.12e-05 | 57 | 31 | 3 | int:ZFP41 | |
| Interaction | ADAM12 interactions | 9.60e-05 | 58 | 31 | 3 | int:ADAM12 | |
| Interaction | KRTAP4-12 interactions | 1.04e-04 | 161 | 31 | 4 | int:KRTAP4-12 | |
| Interaction | KRTAP5-11 interactions | 1.41e-04 | 66 | 31 | 3 | int:KRTAP5-11 | |
| Interaction | PHLDA1 interactions | 1.41e-04 | 66 | 31 | 3 | int:PHLDA1 | |
| Interaction | ZNF417 interactions | 1.54e-04 | 178 | 31 | 4 | int:ZNF417 | |
| Interaction | NR4A3 interactions | 1.61e-04 | 69 | 31 | 3 | int:NR4A3 | |
| Interaction | KRTAP1-3 interactions | 1.75e-04 | 184 | 31 | 4 | int:KRTAP1-3 | |
| Interaction | NGF interactions | 1.77e-04 | 13 | 31 | 2 | int:NGF | |
| Interaction | VGLL3 interactions | 1.83e-04 | 72 | 31 | 3 | int:VGLL3 | |
| Interaction | CHIC2 interactions | 1.91e-04 | 73 | 31 | 3 | int:CHIC2 | |
| Interaction | PTPRN2 interactions | 1.91e-04 | 73 | 31 | 3 | int:PTPRN2 | |
| Interaction | KRTAP4-5 interactions | 2.15e-04 | 76 | 31 | 3 | int:KRTAP4-5 | |
| Interaction | C10orf62 interactions | 2.37e-04 | 15 | 31 | 2 | int:C10orf62 | |
| Interaction | ZNF837 interactions | 2.41e-04 | 79 | 31 | 3 | int:ZNF837 | |
| Interaction | NOTCH2NLA interactions | 2.67e-04 | 381 | 31 | 5 | int:NOTCH2NLA | |
| Interaction | LELP1 interactions | 3.07e-04 | 17 | 31 | 2 | int:LELP1 | |
| Interaction | MMP2 interactions | 3.20e-04 | 87 | 31 | 3 | int:MMP2 | |
| Interaction | CHRD interactions | 4.02e-04 | 94 | 31 | 3 | int:CHRD | |
| Interaction | NBPF19 interactions | 4.29e-04 | 233 | 31 | 4 | int:NBPF19 | |
| Interaction | FAM221A interactions | 4.72e-04 | 21 | 31 | 2 | int:FAM221A | |
| Interaction | MEOX2 interactions | 5.89e-04 | 697 | 31 | 6 | int:MEOX2 | |
| Interaction | SPATA3 interactions | 6.19e-04 | 24 | 31 | 2 | int:SPATA3 | |
| Interaction | NTN5 interactions | 6.19e-04 | 24 | 31 | 2 | int:NTN5 | |
| Interaction | ZNF581 interactions | 6.53e-04 | 111 | 31 | 3 | int:ZNF581 | |
| Interaction | SPRY1 interactions | 6.53e-04 | 111 | 31 | 3 | int:SPRY1 | |
| Interaction | PCSK5 interactions | 6.71e-04 | 112 | 31 | 3 | int:PCSK5 | |
| Interaction | ZNF439 interactions | 7.85e-04 | 27 | 31 | 2 | int:ZNF439 | |
| Interaction | GPRIN2 interactions | 8.44e-04 | 28 | 31 | 2 | int:GPRIN2 | |
| Interaction | HOXB9 interactions | 9.01e-04 | 124 | 31 | 3 | int:HOXB9 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | KRTAP29-1 KRTAP4-4 KRTAP4-7 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-12 ITGB3 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 3.56e-17 | 473 | 37 | 13 | chr17q21 |
| Cytoband | 17q12-q21 | 1.60e-13 | 32 | 37 | 6 | 17q12-q21 | |
| Cytoband | 16q13 | 9.50e-11 | 36 | 37 | 5 | 16q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q13 | 1.65e-10 | 40 | 37 | 5 | chr16q13 | |
| Cytoband | 17q21.2 | 2.99e-09 | 70 | 37 | 5 | 17q21.2 | |
| GeneFamily | Keratin associated proteins | KRTAP29-1 KRTAP4-4 KRTAP4-7 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 1.99e-20 | 109 | 27 | 12 | 619 |
| GeneFamily | Metallothioneins | 5.75e-11 | 19 | 27 | 5 | 638 | |
| GeneFamily | CD molecules|Integrin beta subunits | 7.68e-05 | 9 | 27 | 2 | 1159 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.04e-02 | 394 | 27 | 3 | 471 | |
| Coexpression | PIONTEK_PKD1_TARGETS_UP | 8.01e-07 | 51 | 37 | 4 | MM794 | |
| Coexpression | VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP | 3.91e-06 | 22 | 37 | 3 | MM1299 | |
| Coexpression | LIN_NPAS4_TARGETS_DN | 4.68e-06 | 79 | 37 | 4 | MM1239 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 7.40e-06 | 27 | 37 | 3 | MM643 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP | 8.28e-06 | 28 | 37 | 3 | MM487 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 9.68e-06 | 204 | 37 | 5 | MM966 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 1.20e-05 | 100 | 37 | 4 | MM514 | |
| Coexpression | BRACHAT_RESPONSE_TO_METHOTREXATE_DN | 2.11e-05 | 38 | 37 | 3 | MM1161 | |
| Coexpression | HOUSTIS_ROS | 3.30e-05 | 44 | 37 | 3 | MM1142 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON | 3.57e-05 | 132 | 37 | 4 | M3434 | |
| Coexpression | MA_MYELOID_DIFFERENTIATION_UP | 3.77e-05 | 46 | 37 | 3 | MM640 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 4.24e-05 | 138 | 37 | 4 | MM1047 | |
| Coexpression | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP | 4.29e-05 | 48 | 37 | 3 | MM649 | |
| Coexpression | RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP | 5.40e-05 | 8 | 37 | 2 | M41082 | |
| Coexpression | WANG_TARGETS_OF_MLL_CBP_FUSION_UP | 5.46e-05 | 52 | 37 | 3 | MM628 | |
| Coexpression | HEVNER_CORTEX_CAUDAL_VENTRICULAR_ZONE | 5.46e-05 | 52 | 37 | 3 | MM442 | |
| Coexpression | LEIN_ASTROCYTE_MARKERS | 6.11e-05 | 54 | 37 | 3 | MM715 | |
| Coexpression | BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN | 6.11e-05 | 54 | 37 | 3 | MM1195 | |
| Coexpression | JIANG_AGING_HYPOTHALAMUS_UP | 7.57e-05 | 58 | 37 | 3 | MM703 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 7.97e-05 | 59 | 37 | 3 | MM952 | |
| Coexpression | NAKAMURA_ADIPOGENESIS_EARLY_UP | 9.70e-05 | 63 | 37 | 3 | M2024 | |
| Coexpression | NADLER_OBESITY_UP | 1.17e-04 | 67 | 37 | 3 | MM1007 | |
| Coexpression | LUDWICZEK_TREATING_IRON_OVERLOAD | 1.27e-04 | 12 | 37 | 2 | MM792 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.62e-04 | 369 | 37 | 5 | MM16610 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN | 1.75e-04 | 199 | 37 | 4 | M5230 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN | 1.78e-04 | 200 | 37 | 4 | M6626 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.78e-04 | 200 | 37 | 4 | M5930 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN | 1.78e-04 | 200 | 37 | 4 | M5228 | |
| Coexpression | ZHENG_RESPONSE_TO_ARSENITE_UP | 2.01e-04 | 15 | 37 | 2 | M1589 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 2.23e-04 | 212 | 37 | 4 | MM3816 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 2.28e-04 | 84 | 37 | 3 | MM873 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP | 2.30e-04 | 16 | 37 | 2 | MM1089 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 2.74e-04 | 650 | 37 | 6 | MM1042 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 2.95e-04 | 659 | 37 | 6 | MM1040 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_UP | 3.08e-04 | 93 | 37 | 3 | MM850 | |
| Coexpression | ZHANG_UTERUS_C2_REGENERATIVE_UP | 3.48e-04 | 97 | 37 | 3 | MM16605 | |
| Coexpression | SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP | 4.81e-04 | 23 | 37 | 2 | MM1198 | |
| Coexpression | LU_AGING_BRAIN_UP | 5.04e-04 | 263 | 37 | 4 | M5547 | |
| Coexpression | JEON_SMAD6_TARGETS_UP | 5.25e-04 | 24 | 37 | 2 | M4592 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 6.76e-04 | 504 | 37 | 5 | MM830 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN | 6.81e-04 | 122 | 37 | 3 | M6677 | |
| Coexpression | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP | 7.16e-04 | 28 | 37 | 2 | MM707 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 7.31e-04 | 125 | 37 | 3 | MM1065 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 7.48e-04 | 126 | 37 | 3 | MM3711 | |
| Coexpression | MA_RAT_AGING_UP | 7.65e-04 | 127 | 37 | 3 | MM16096 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_MACROPHAGE_AGEING | 7.83e-04 | 128 | 37 | 3 | MM3838 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 8.37e-04 | 131 | 37 | 3 | MM1127 | |
| Coexpression | GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN | 9.13e-04 | 135 | 37 | 3 | M6344 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 9.33e-04 | 136 | 37 | 3 | MM3747 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_T_CELL_AGEING | 9.60e-04 | 545 | 37 | 5 | MM3785 | |
| Coexpression | HALLMARK_COAGULATION | 9.73e-04 | 138 | 37 | 3 | M5946 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | 1.01e-03 | 317 | 37 | 4 | MM956 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN | 1.04e-03 | 141 | 37 | 3 | M11896 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP | 1.10e-03 | 144 | 37 | 3 | M9003 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.78e-06 | 146 | 30 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_500 | 6.98e-06 | 193 | 30 | 5 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 9.80e-06 | 207 | 30 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | 1.82e-05 | 858 | 30 | 8 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-1 | 1.92e-05 | 407 | 30 | 6 | GSM854287_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 2.53e-05 | 122 | 30 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.57e-05 | 475 | 30 | 6 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k1_1000 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_top-relative-expression-ranked_500 | 4.71e-05 | 287 | 30 | 5 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.89e-05 | 311 | 30 | 5 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | 9.77e-05 | 797 | 30 | 7 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.01e-04 | 337 | 30 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | ECTO amniotic fluid MSC_vs_ECTO blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.23e-04 | 183 | 30 | 4 | PCBC_ratio_ECTO amniotic fluid MSC_vs_ECTO blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 1.23e-04 | 827 | 30 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.27e-04 | 354 | 30 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 1.27e-04 | 831 | 30 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | 1.45e-04 | 849 | 30 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.LuLN, MHCII+ CD11c+ CD8- CD11b+ CD103-, Lymph Node, avg-3 | 1.48e-04 | 366 | 30 | 5 | GSM854255_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 1.67e-04 | 76 | 30 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_200 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_top-relative-expression-ranked_1000 | 1.78e-04 | 608 | 30 | 6 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 1.87e-04 | 385 | 30 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang-103-11blo.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b-, Lymph Node, avg-3 | 1.90e-04 | 386 | 30 | 5 | GSM538277_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 1.94e-04 | 388 | 30 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang-103-11b+.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b+, Lymph Node, avg-3 | 2.53e-04 | 411 | 30 | 5 | GSM538274_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 2.74e-04 | 418 | 30 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 2.89e-04 | 423 | 30 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | 3.19e-04 | 432 | 30 | 5 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | 3.39e-04 | 975 | 30 | 7 | PCBC_ctl_CardiacMyocyte_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.43e-04 | 97 | 30 | 3 | GSM777046_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.03e-04 | 265 | 30 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.23e-04 | 112 | 30 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 6.20e-04 | 768 | 30 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 6.41e-04 | 773 | 30 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 6.59e-04 | 777 | 30 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_500 | 6.87e-04 | 123 | 30 | 3 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.88e-04 | 288 | 30 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_100 | 7.13e-04 | 28 | 30 | 2 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_100_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.37e-04 | 126 | 30 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.10e-03 | 327 | 30 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 1.13e-03 | 146 | 30 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.15e-03 | 147 | 30 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.29e-03 | 153 | 30 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_200 | 1.46e-03 | 40 | 30 | 2 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k4_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_200 | 1.52e-03 | 162 | 30 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 1.52e-03 | 357 | 30 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 1.53e-03 | 41 | 30 | 2 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k2_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.60e-03 | 42 | 30 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 1.64e-03 | 364 | 30 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.79e-03 | 373 | 30 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_NA_vs_Endoderm Differentiated Cells-method_mRNA-Confounder_removed-fold2.0_adjp0.05 | 1.84e-03 | 45 | 30 | 2 | PCBC_ratio_DE_from-ESC_vs_DE_from-mRNA_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_NA_vs_Endoderm Differentiated Cells-reprogram_OSKM-L-Confounder_removed-fold2.0_adjp0.05 | 1.84e-03 | 45 | 30 | 2 | PCBC_ratio_DE_from-ESC_vs_DE_from-OSKM-L_cfr-2X-p05 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.LuLN, MHCII+ CD11c+ CD8- CD11b- CD103+, Lymph Node, avg-3 | 1.84e-03 | 376 | 30 | 4 | GSM854243_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.87e-03 | 951 | 30 | 6 | Arv_EB-LF_2500_K2 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 2.04e-03 | 967 | 30 | 6 | PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP29-1 KRTAP4-4 KRTAP4-6 MT4 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP4-11 KRTAP1-1 | 1.48e-21 | 146 | 37 | 12 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KRTAP4-4 KRTAP4-7 KRTAP4-6 KRTAP4-9 KRTAP4-1 KRTAP4-2 KRTAP4-8 | 1.61e-11 | 133 | 37 | 7 | f7d0763b5eec2db33044d6850fd57462494038c1 |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.07e-09 | 129 | 37 | 6 | 6a201c6344a015e5cf2f79ccf397fd7ad66b6768 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.71e-08 | 106 | 37 | 5 | 117b53d525be929652fb998e250d7946170fbaf0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 195 | 37 | 4 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 195 | 37 | 4 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 2.10e-05 | 197 | 37 | 4 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-05 | 197 | 37 | 4 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-05 | 198 | 37 | 4 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-05 | 198 | 37 | 4 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.19e-05 | 199 | 37 | 4 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.23e-05 | 200 | 37 | 4 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Slc17a7-Slc17a6.Calb1-Rorb-Il1rapl2_(Layer_5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.03e-05 | 80 | 37 | 3 | 402aba070f0728ebda9db7a8fa85441533755ff4 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-6|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.04e-04 | 110 | 37 | 3 | ebf871bf29796caf25dd83a587774efe7f7c79ec | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-04 | 146 | 37 | 3 | cffa91d76606f74553d81150adbb23b003746316 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.70e-04 | 152 | 37 | 3 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-04 | 154 | 37 | 3 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-04 | 154 | 37 | 3 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Batf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.97e-04 | 157 | 37 | 3 | 921805932f7974d37aed547861d555b07f30aba6 | |
| ToppCell | lung-Club_Cells|lung / shred on tissue and cell subclass | 3.37e-04 | 164 | 37 | 3 | b12cacd499b18b96120ca6d14646aebeaed41d10 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 168 | 37 | 3 | f45dbcd7753117a3e41e1412bce2100d52fa7fd0 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-04 | 169 | 37 | 3 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-04 | 169 | 37 | 3 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.75e-04 | 170 | 37 | 3 | 67415b098e8ba815b501e557192a9f2b10ee995a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.94e-04 | 173 | 37 | 3 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 4.15e-04 | 176 | 37 | 3 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|normal_Lung / Location, Cell class and cell subclass | 4.15e-04 | 176 | 37 | 3 | f31d7234053085a82cf9d55aeedd1e04d34789c3 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.15e-04 | 176 | 37 | 3 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-04 | 176 | 37 | 3 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-04 | 176 | 37 | 3 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|metastatic_Brain / Location, Cell class and cell subclass | 4.36e-04 | 179 | 37 | 3 | 56fe381ffbaba3a4f2f587a3e367b0d11fbd4a2a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-04 | 179 | 37 | 3 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.43e-04 | 180 | 37 | 3 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-04 | 180 | 37 | 3 | d553aba594f5304f1c09ff9c6d49b64cd7ee7850 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-04 | 181 | 37 | 3 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-04 | 182 | 37 | 3 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-04 | 182 | 37 | 3 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.57e-04 | 182 | 37 | 3 | 1adb8d6404d50155e9f9ba805abef63929fe865f | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.57e-04 | 182 | 37 | 3 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-04 | 182 | 37 | 3 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-04 | 183 | 37 | 3 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 184 | 37 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.72e-04 | 184 | 37 | 3 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 184 | 37 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 184 | 37 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-04 | 184 | 37 | 3 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 4.79e-04 | 185 | 37 | 3 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.79e-04 | 185 | 37 | 3 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-04 | 186 | 37 | 3 | ed0a91f47e77fe21d4c7678d0f2a7c5f97d63dda | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 187 | 37 | 3 | 1669df899b1759c338ffce196fe009840123cfcd | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 187 | 37 | 3 | f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.02e-04 | 188 | 37 | 3 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.02e-04 | 188 | 37 | 3 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.02e-04 | 188 | 37 | 3 | 1a751452c0f1f34b3c20fad2fb52c378ab2d0207 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.10e-04 | 189 | 37 | 3 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.10e-04 | 189 | 37 | 3 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-04 | 190 | 37 | 3 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.18e-04 | 190 | 37 | 3 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-04 | 190 | 37 | 3 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-04 | 190 | 37 | 3 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.18e-04 | 190 | 37 | 3 | ad0d9aed8c9c99551765d14730d70ebef1ea856b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-04 | 190 | 37 | 3 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells|World / Lineage, cell class and subclass | 5.18e-04 | 190 | 37 | 3 | 72b61a12ccea506272ce9cef9051aa2612e6ce57 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 191 | 37 | 3 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 191 | 37 | 3 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 191 | 37 | 3 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 191 | 37 | 3 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 191 | 37 | 3 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 191 | 37 | 3 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 191 | 37 | 3 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.26e-04 | 191 | 37 | 3 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 191 | 37 | 3 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 191 | 37 | 3 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 191 | 37 | 3 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 191 | 37 | 3 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 191 | 37 | 3 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 192 | 37 | 3 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.34e-04 | 192 | 37 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 192 | 37 | 3 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 192 | 37 | 3 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.34e-04 | 192 | 37 | 3 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 192 | 37 | 3 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.34e-04 | 192 | 37 | 3 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.34e-04 | 192 | 37 | 3 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.34e-04 | 192 | 37 | 3 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 192 | 37 | 3 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.34e-04 | 192 | 37 | 3 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 5.34e-04 | 192 | 37 | 3 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.34e-04 | 192 | 37 | 3 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 192 | 37 | 3 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.34e-04 | 192 | 37 | 3 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-04 | 193 | 37 | 3 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 5.42e-04 | 193 | 37 | 3 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-04 | 193 | 37 | 3 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.42e-04 | 193 | 37 | 3 | a313541cedfcff8fb311b9bc60157359aa103830 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-04 | 194 | 37 | 3 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-04 | 194 | 37 | 3 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.51e-04 | 194 | 37 | 3 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-04 | 194 | 37 | 3 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | IPF-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 5.51e-04 | 194 | 37 | 3 | d8a26da856a85e3d001d406e992cb18fdd58baef | |
| Drug | dicarboxymethyldithiocarbamate | 6.59e-10 | 9 | 36 | 4 | CID000130472 | |
| Drug | CAPSO-DTC | 6.59e-10 | 9 | 36 | 4 | CID003081023 | |
| Drug | PmMT | 1.10e-09 | 10 | 36 | 4 | CID000085248 | |
| Drug | 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridine | 1.10e-09 | 10 | 36 | 4 | CID000819992 | |
| Drug | CAP-N-DTC | 1.72e-09 | 11 | 36 | 4 | CID000125337 | |
| Drug | MeOBGDTC | 1.72e-09 | 11 | 36 | 4 | CID000119173 | |
| Drug | alpha-mercapto-beta-(2-furyl)acrylic acid | 3.72e-09 | 13 | 36 | 4 | CID006437871 | |
| Drug | diamsar | 5.21e-09 | 14 | 36 | 4 | CID000146286 | |
| Drug | Cadmium-thionein | 5.21e-09 | 14 | 36 | 4 | CID000198548 | |
| Drug | MT45 | 7.09e-09 | 15 | 36 | 4 | CID000431865 | |
| Drug | urs-12-ene-3beta,28-diol | 7.09e-09 | 15 | 36 | 4 | CID000092802 | |
| Drug | ZnATP | 1.23e-08 | 17 | 36 | 4 | CID006455240 | |
| Drug | bismuth nitrate | 1.23e-08 | 17 | 36 | 4 | CID000107711 | |
| Drug | azelaic bishydroxamic acid | 1.23e-08 | 17 | 36 | 4 | CID000065268 | |
| Drug | AC1O3QMZ | 2.01e-08 | 19 | 36 | 4 | CID006334573 | |
| Drug | 4-(2-pyridylazo)resorcinol | 3.09e-08 | 21 | 36 | 4 | CID000104300 | |
| Drug | cadmium oxide | 3.09e-08 | 21 | 36 | 4 | CID000014782 | |
| Drug | 4-(2-pyridylazo)resorcinol | 3.77e-08 | 22 | 36 | 4 | CID005370169 | |
| Drug | zinc hydroxide | 3.77e-08 | 22 | 36 | 4 | CID000062742 | |
| Drug | iproplatin | 4.56e-08 | 23 | 36 | 4 | CID003034746 | |
| Drug | manganese sulfate monohydrate | 4.56e-08 | 23 | 36 | 4 | CID000166832 | |
| Drug | hinokitiol | 6.50e-08 | 25 | 36 | 4 | CID000003611 | |
| Drug | MT20 | 7.67e-08 | 26 | 36 | 4 | CID003025942 | |
| Drug | BGDTC | 7.67e-08 | 26 | 36 | 4 | CID000105107 | |
| Drug | Oral-Turinabol | 9.00e-08 | 27 | 36 | 4 | CID000098521 | |
| Drug | Zinc chromate hydroxide | 1.22e-07 | 29 | 36 | 4 | CID000027567 | |
| Drug | Ormaplatino | 1.61e-07 | 31 | 36 | 4 | CID006434704 | |
| Drug | alpha-hederin | 1.83e-07 | 32 | 36 | 4 | CID000073296 | |
| Drug | zinc acetate dihydrate | 2.08e-07 | 33 | 36 | 4 | CID000636168 | |
| Drug | Zinquin | 2.08e-07 | 33 | 36 | 4 | CID000132933 | |
| Drug | DEDTC | 2.36e-07 | 34 | 36 | 4 | CID000032064 | |
| Drug | rhodanine | 2.36e-07 | 34 | 36 | 4 | CID001201546 | |
| Drug | p-hydroxyphenyllactic acid | 2.99e-07 | 36 | 36 | 4 | CID000009378 | |
| Drug | methylcyclopentadienyl)manganese tricarbonyl | 3.35e-07 | 37 | 36 | 4 | CID005150494 | |
| Drug | genistin | 3.74e-07 | 38 | 36 | 4 | CID005281377 | |
| Drug | cerium | 4.16e-07 | 39 | 36 | 4 | CID000008762 | |
| Drug | 1q1g | 4.16e-07 | 39 | 36 | 4 | CID000447992 | |
| Drug | 6-aminonicotinamide | 4.16e-07 | 39 | 36 | 4 | CID000009500 | |
| Drug | CdCl2 | 4.52e-07 | 98 | 36 | 5 | CID000024947 | |
| Drug | arsenic(III | 4.62e-07 | 40 | 36 | 4 | CID000104734 | |
| Drug | bismuth | 5.64e-07 | 42 | 36 | 4 | CID000105143 | |
| Drug | trans-DDP | 6.83e-07 | 44 | 36 | 4 | CID000084691 | |
| Drug | AC1L45V9 | 7.49e-07 | 45 | 36 | 4 | CID000151205 | |
| Drug | trien | 8.19e-07 | 46 | 36 | 4 | CID000005565 | |
| Drug | midodrine | 8.94e-07 | 47 | 36 | 4 | CID000004195 | |
| Drug | neutral red | 8.94e-07 | 47 | 36 | 4 | CID000011105 | |
| Drug | octachloronaphthalene | 8.94e-07 | 47 | 36 | 4 | CID000016692 | |
| Drug | DL-propargylglycine | 9.74e-07 | 48 | 36 | 4 | CID000095575 | |
| Drug | dimercaprol | 9.74e-07 | 48 | 36 | 4 | CID000003080 | |
| Drug | isopropanol | 1.34e-06 | 122 | 36 | 5 | CID000003776 | |
| Drug | auranofin | 1.35e-06 | 52 | 36 | 4 | CID006918453 | |
| Drug | dimethylmercury | 1.35e-06 | 52 | 36 | 4 | CID000011645 | |
| Drug | oleanolic acid | 1.35e-06 | 52 | 36 | 4 | CID000010494 | |
| Drug | Ridauran | 1.69e-06 | 55 | 36 | 4 | CID006333887 | |
| Drug | CH3Hg | 2.41e-06 | 60 | 36 | 4 | CID000007905 | |
| Drug | tetrathiomolybdate | 2.58e-06 | 61 | 36 | 4 | CID005245480 | |
| Drug | Disperse Blue 7 | 2.58e-06 | 61 | 36 | 4 | CID000018514 | |
| Drug | ZnSO4.7H2O | 2.93e-06 | 63 | 36 | 4 | CID000062639 | |
| Drug | Leu-asp-val | 4.06e-06 | 20 | 36 | 3 | CID000130816 | |
| Drug | zinc sulfate | 4.23e-06 | 69 | 36 | 4 | CID000024424 | |
| Drug | L-beta-aspartyl phosphate | 4.23e-06 | 69 | 36 | 4 | CID000000832 | |
| Drug | ursolic acid | 5.02e-06 | 72 | 36 | 4 | CID000064945 | |
| Drug | fluoroacetic acid | 5.02e-06 | 72 | 36 | 4 | CID000005236 | |
| Drug | Fe-NTA | 5.30e-06 | 73 | 36 | 4 | CID000027880 | |
| Drug | sarcolysin | 7.24e-06 | 172 | 36 | 5 | CID000004053 | |
| Drug | AC1L1JM9 | 7.50e-06 | 304 | 36 | 6 | CID000005103 | |
| Drug | selenium | 7.64e-06 | 80 | 36 | 4 | CID006326970 | |
| Drug | selenide ion | 8.55e-06 | 178 | 36 | 5 | CID000107674 | |
| Drug | cilostazol | 1.02e-05 | 86 | 36 | 4 | CID000002754 | |
| Drug | methyl red | 1.02e-05 | 86 | 36 | 4 | CID000010303 | |
| Drug | acetylbetulinic acid | 1.12e-05 | 88 | 36 | 4 | CID000289984 | |
| Drug | CuSO4 | 1.33e-05 | 92 | 36 | 4 | CID000024462 | |
| Drug | S-nitrosocysteine | 1.39e-05 | 93 | 36 | 4 | CID003359494 | |
| Drug | tris(1,10-phenanthroline)chromium(III) chloride | 1.46e-05 | 4 | 36 | 2 | ctd:C495433 | |
| Drug | rutin | 1.71e-05 | 98 | 36 | 4 | CID005280805 | |
| Drug | TPEN | 1.85e-05 | 100 | 36 | 4 | CID000005519 | |
| Drug | diethyldithiocarbamate | 1.93e-05 | 101 | 36 | 4 | CID000008987 | |
| Drug | p-terphenyl | 2.08e-05 | 103 | 36 | 4 | CID000007115 | |
| Drug | fluconazole | 2.42e-05 | 107 | 36 | 4 | CID000003365 | |
| Drug | 2-(2,6-dioxopiperidin-3-yl)phthalimidine | 2.42e-05 | 5 | 36 | 2 | ctd:C001079 | |
| Drug | bis(N,N-diethyldithiocarbamate)Cu (II) complex | 2.42e-05 | 5 | 36 | 2 | ctd:C067982 | |
| Drug | zinc superoxide | 2.51e-05 | 108 | 36 | 4 | CID000014809 | |
| Drug | buthionine sulfoximine | 2.88e-05 | 229 | 36 | 5 | CID000021157 | |
| Drug | thiobarbituric acid | 3.55e-05 | 118 | 36 | 4 | CID002723628 | |
| Drug | Silver Nitrate | 3.67e-05 | 119 | 36 | 4 | ctd:D012835 | |
| Drug | Cys-cys | 3.67e-05 | 119 | 36 | 4 | CID000152238 | |
| Drug | NiCl2 | 3.67e-05 | 119 | 36 | 4 | CID000024385 | |
| Drug | azathioprine | 3.79e-05 | 120 | 36 | 4 | CID000002265 | |
| Drug | AC1L1Z2L | 4.18e-05 | 123 | 36 | 4 | CID000012201 | |
| Drug | Hcys | 4.38e-05 | 250 | 36 | 5 | CID000000594 | |
| Drug | chlorambucil | 5.67e-05 | 133 | 36 | 4 | CID000002708 | |
| Drug | arsenate | 6.01e-05 | 135 | 36 | 4 | CID000000233 | |
| Drug | acrolein | 6.18e-05 | 136 | 36 | 4 | CID000007847 | |
| Drug | DL-penicillamine | 6.73e-05 | 139 | 36 | 4 | CID000004727 | |
| Drug | cisplatin | 6.73e-05 | 139 | 36 | 4 | CID000002767 | |
| Drug | ozone | 7.52e-05 | 143 | 36 | 4 | CID000024823 | |
| Drug | motexafin gadolinium | 8.15e-05 | 146 | 36 | 4 | ctd:C437683 | |
| Drug | vanadium | 8.82e-05 | 149 | 36 | 4 | CID000023990 | |
| Drug | lead compounds | 9.05e-05 | 150 | 36 | 4 | CID000073212 | |
| Drug | 5,5'-dithiobis(2-nitrobenzoic acid | 1.08e-04 | 157 | 36 | 4 | CID000006254 | |
| Disease | retinitis pigmentosa (biomarker_via_orthology) | 9.20e-10 | 13 | 33 | 4 | DOID:10584 (biomarker_via_orthology) | |
| Disease | median neuropathy (biomarker_via_orthology) | 1.29e-09 | 14 | 33 | 4 | DOID:571 (biomarker_via_orthology) | |
| Disease | kidney failure (biomarker_via_orthology) | 4.96e-09 | 19 | 33 | 4 | DOID:1074 (biomarker_via_orthology) | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 5.60e-09 | 58 | 33 | 5 | DOID:10652 (biomarker_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 8.42e-07 | 157 | 33 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 1.43e-06 | 20 | 33 | 3 | DOID:2921 (biomarker_via_orthology) | |
| Disease | aortic aneurysm | 5.43e-05 | 10 | 33 | 2 | EFO_0001666 | |
| Disease | Autism Spectrum Disorders | 1.18e-04 | 85 | 33 | 3 | C1510586 | |
| Disease | Gliosis | 1.63e-04 | 17 | 33 | 2 | C0017639 | |
| Disease | Astrocytosis | 1.63e-04 | 17 | 33 | 2 | C3887640 | |
| Disease | hair morphology | 4.83e-04 | 29 | 33 | 2 | EFO_0005038 | |
| Disease | spontaneous coronary artery dissection | 5.53e-04 | 31 | 33 | 2 | EFO_0010820 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 8.87e-04 | 169 | 33 | 3 | DOID:3908 (is_marker_for) | |
| Disease | Liver Cirrhosis, Experimental | 1.58e-03 | 774 | 33 | 5 | C0023893 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CAMCSLANISLCGSC | 436 | O60477 | |
| MCSSCQEAGATIGCC | 1856 | Q7Z5J4 | |
| QGQTCEMCQTCLGVC | 626 | P05556 | |
| CMCDHGQVTCQTGEC | 306 | Q86XX4 | |
| TCVGHCSNGGSCTMN | 4376 | Q07954 | |
| MVNSCCGSVCSHQGC | 1 | Q9BYQ6 | |
| MVNSCCGSVCSDQGC | 1 | Q9BQ66 | |
| MACCQTSFCGFPSCS | 1 | Q07627 | |
| MVNSCCGSVCSDQGC | 1 | Q9BYQ7 | |
| MVNSCCGSVCSDQGC | 1 | Q9BYR5 | |
| MVSSCCGSVCSDQSC | 1 | Q9BYR4 | |
| MVNSCCGSVCSDQGC | 1 | Q9BYR3 | |
| MDPNCSCATGGSCTC | 1 | P04732 | |
| GELCMNSAQCKSNCC | 31 | P04118 | |
| CVCMSGGICMCGDNC | 6 | P47944 | |
| NASCTNTEGGYTCMC | 926 | P01133 | |
| VCACDSQGNMQSCSA | 586 | Q9Y6N8 | |
| CSIMNGGCETFCTNS | 1201 | P35555 | |
| CSNCTSNGMECMWCS | 896 | Q5VV63 | |
| MCSGHGQCSCGDCLC | 561 | P05106 | |
| MVSSCCGSVCSDQGC | 1 | Q9BYQ5 | |
| MVSSCCGSVCSDQGC | 1 | Q9BYR0 | |
| MVNSCCGSVCSDQGC | 1 | Q9BYQ9 | |
| MVSSCCGSVCSDQGC | 1 | Q9BYQ8 | |
| CQESVCMSGSCQAAC | 131 | A8MX34 | |
| CMSGSCQAACGQSVC | 136 | A8MX34 | |
| CQAACGQSVCCDAGS | 141 | A8MX34 | |
| CSMSNGSCDQGCVNT | 366 | Q8IWY4 | |
| CAEGNGGCQQSCVNM | 116 | Q8IX30 | |
| MDPNCSCATGGSCTC | 1 | P04731 | |
| MDPNCSCTTGGSCAC | 1 | P07438 | |
| MDPNCSCATGGSCSC | 1 | Q93083 | |
| SCNHMTCAVCGCEFC | 301 | Q6ZMZ0 | |
| CNNCTCVSGKMACTS | 2966 | A2VEC9 | |
| TCCLNGGTCMLGSFC | 81 | P13385 | |
| MGICSSCNFAFCTLC | 326 | Q9UBS8 | |
| MSAQCCAGQLACCCG | 1 | Q86VE9 | |
| ASGGNDCTTSTACMC | 366 | Q5SRE5 | |
| CKCNTGFNGTACEMC | 1986 | Q8WWQ8 | |
| TCCLNGGTCMLESFC | 81 | P51864 | |
| TNKICCSAFCGNICM | 56 | Q8IUB3 |